Xarelto and Abdominal wall haematoma - a phase IV clinical study of FDA data
Abdominal wall haematoma is found among people who take Xarelto, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Xarelto and have Abdominal wall haematoma. It is created by eHealthMe based on reports of 195,181 people who have side effects when taking Xarelto from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
195,181 people reported to have side effects when taking Xarelto.
Among them, 369 people (0.19%) have Abdominal wall haematoma.
What is Xarelto?
Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 197,025 Xarelto users for its effectiveness, alternative drugs and more.
What is Abdominal wall haematoma?
Abdominal wall haematoma (abdominal wall blood clotting) is found to be associated with 825 drugs and 489 conditions by eHealthMe.
Number of Xarelto and Abdominal wall haematoma reports submitted per year:
Time on Xarelto when people have Abdominal wall haematoma *:
Gender of people who have Abdominal wall haematoma when taking Xarelto*:
Age of people who have Abdominal wall haematoma when taking Xarelto *:
Common drugs people take besides Xarelto *:
Common side effects people have besides Abdominal wall haematoma *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Xarelto and have Abdominal wall haematoma?Check whether Abdominal wall haematoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Abdominal wall haematoma and when was it recovered:
Expand to all the drugs that have ingredients of rivaroxaban:
Alternative drugs to, pros and cons of Xarelto:
- Xarelto (197,025 reports)
Common Xarelto side effects:
Browse all side effects of Xarelto:a b c d e f g h i j k l m n o p q r s t u v w x y z
Abdominal wall haematoma treatments and more:
- Abdominal wall haematoma (1,984 reports)
COVID vaccines that are related to Abdominal wall haematoma:
- Abdominal wall haematoma in Moderna COVID Vaccine
- Abdominal wall haematoma in Pfizer BioNTech Covid Vaccine
- Abdominal wall haematoma in Johnson and Johnson Covid Vaccine
Common drugs associated with Abdominal wall haematoma:
- Acetylsalicylic acid: 120 reports
- Aspirin: 259 reports
- Furosemide: 118 reports
- Heparin: 155 reports
- Lasix: 109 reports
- Lovenox: 141 reports
- Xarelto: 369 reports
All the drugs that are associated with Abdominal wall haematoma:
- Abdominal wall haematoma (825 drugs)
Common conditions associated with Abdominal wall haematoma:
All the conditions that are associated with Abdominal wall haematoma:
- Abdominal wall haematoma (489 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Xarelto) and Xarelto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Relpax and Glaucoma - 3 seconds ago
- Triamcinolone and White Blood Cell Count Decreased - 9 seconds ago
- Valproic Acid and Gynecomastia - 15 seconds ago
- Yasmin and Ramelteon drug interaction - 20 seconds ago
- Mercaptopurine and Neurogenic Bladder - 21 seconds ago
- Hydramine and Leukopenia - 25 seconds ago
- Ventricular Tachycardia and Atrial Fibrillation/Flutter - 25 seconds ago
- Lisinopril and Renova drug interaction - 36 seconds ago
- Theo-24 and Fainting - 40 seconds ago
- Flax Seed and Arimidex drug interaction - 48 seconds ago